Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: Long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan)

Bone Marrow Transplantation

Volumn 20, Issue 9, 1997, Pages 731-735

  Deconinck, E ^a   Cahn, J Y ^a   Milpied, N ^b   Jouet, J P ^c   Vernant, J P ^d   Esperou, H ^e   Lioure, B ^f   Bordigoni, P ^g   Leblond, V ^h   Troussard, X ⁱ   Caillot, D ^j   Cordonnier, J M ^a   Herve P ^a  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^b HÔTEL DIEU   (France)

^c Oscar Lambret Institute   (France)

^d HENRI MONDOR HOSPITAL   (France)

^e SAINT LOUIS HOSPITAL   (France)

^f HÔPITAL DE HAUTEPIERRE   (France)

^g CHU NANCY BRABOIS   (France)

^h PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

ⁱ CAEN UNIVERSITY HOSPITAL   (France)

^j HÔPITAL DU BOCAGE   (France)

more..

Author keywords

Acute lymphoblastic leukemia; Bone marrow transplantation; Cytosine arabinoside; Melphalan; Total body irradiation

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; MELPHALAN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; DRUG TOXICITY; FEMALE; HUMAN; MALE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 0030683559     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700964     Document Type: Article

References (39)

1. Cortes JE, Kantarjian HM. Acute lymphoblastic leukemia. A comprehensive review with emphasis on biology and therapy. Cancer 1995; 76: 2393-2417.
2. Copelan EA, McGuire EA. The biology of acute lymphoblastic leukemia in adults. Blood 1995; 85: 1151-1168.
3. Giralt SA, Champlin RE. Leukemia relapse after allogeneic bone marrow transplantation: a review. Blood 1994; 84: 3603-3612.
4. Attal M, Blaise D, Marit G et al. Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. Blood 1995; 86: 1619-1628.
5. Fière D, Lepage E, Sebban C et al. Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as post-remission therapy. J Clin Oncol 1993; 11: 1990-2001.
6. Horowitz MM, Messerer D, Hoelzer D et al. Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission. Ann Intern Med 1991; 115: 13-18.
7. Kersey JH, Weisdorf D, Nesbit ME et al. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high risk refractory acute lymphoblastic leukemia. New Engl J Med 1987; 317: 461-467.
8. Proctor SJ, Hamilton PJ, Reid MM et al. A comparative study of combination chemotherapy versus bone marrow transplantation in first remission ALL. Bone Marrow Transplant 1987; 21 (Suppl. 1): 21.
9. Sebban C, Lepage E, Vernant JP et al. Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. J Clin Oncol 1994; 12: 2580-2587.
10. Zander AR, Keating M, Dicke K et al. A comparison of marrow transplantation for adults with acute leukemia of poor prognosis in first complete remission. J Clin Oncol 1988; 6: 1548-1557.
11. Gale RP, Champlin RE. How does marrow transplantation cure leukemia? Lancet 1984; 2: 28-32.
12. Horowitz MM, Gale RP, Sondel PM et al. Graft versus leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555-562.
13. Weisdorf D, Nesbit ME, Ramsay NK et al. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft-versus-host disease. J Clin Oncol 1987; 5: 1348-1355.
14. De Witte T, Awwad B, Boezeman J et al. Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission. Bone Marrow Transplant 1994; 14: 767-774.
15. Frassoni F, Labopin M, Gluckman E et al. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time - a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT). Bone Marrow Transplant 1996; 17: 13-18.
16. Coccia PF, Strandjord SE, Warkentin PI et al. High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission. Blood 1988; 71: 888-893.
17. Champlin R, Jacobs A, Gale RP et al. High-dose cytarabine in consolidation chemotherapy or with bone marrow transplantation for patients with acute leukemia: preliminary results. Semin Oncol 1985; 12: 190-195.
18. Herzig RH, Wolff SN, Lazarus HM et al. High-dose cytosine arabinoside therapy for refractory leukemia. Blood 1993; 62: 361-369.
19. Krance RA, Forman SJ, Blume KG. Total-body irradiation and high-dose teniposide: a pilot study in bone marrow transplantation for patients with relapsed acute lymphoblastic leukemia. Cancer Treat Rep 1987; 71: 645-647.
20. Maraninchi D, Pico JL, Hartmann C et al. High-dose melphalan with or without marrow transplantation: a study of dose effect in patients with refractory and/or relapsed acute leukemias. Cancer Treat Rep 1986; 70: 445-448.
21. Riddell S, Appelbaum FR, Buckner CD et al. High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia. J Clin Oncol 1988; 6: 576-582.
22. Cahn JY, Plouvier E, Flesch M et al. Total body irradiation, high-dose cytosine arabinoside and high-dose melphalan: a phase II study. In Dicke KA, Spitzer G, Jagannath S (eds). Autologous Bone Marrow Transplantation III. Symposium. MD Anderson Cancer Center: Houston, TX, University of Texas, 1987, pp 601-604.
23. Cahn JY, Hervé P, Souillet G et al. The TAM protocol as conditioning regimen prior to BMT for high-risk acute leukemias: a multicentre study of 48 patients. Bone Marrow Transplant 1988; 3 (Suppl. 1): 187.
24. Cahn JY, Bordigoni P, Souillet G et al. The TAM regimen prior to allogeneic and autologous bone marrow transplantation for high-risk acute lymphoblastic leukemias: a cooperative study of 62 patients. Bone Marrow Transplant 1991; 7: 1-4.
25. Bordigoni P, Gluckman E, Souillet G et al. Total body irradiation, high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation for therapy of relapsed acute lymphoblastic leukemia in childhood. Blood 1991; 10: 78 (Abstr.).
26. Moussalem M, Esperou-Bourdeau H, Devergie A et al. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease. Bone Marrow Transplant 1995; 15: 943-947.
27. Bennett JM, Catovsky D, Daniel MT et al. Proposals for the classification of the acute leukemias. Br J Haematol 1976; 33: 451-458.
28. Barrett AJ, Horowitz MM, Gale RP et al. Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival. Blood 1989; 74: 862-871.
29. Hoelzer D, Thiel E, Löffler H et al. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 1988; 71: 123-131.
30. Glucksberg H, Storb R, Fefer A et al. Clinical manifestation of GVHD in human recipients of marrow from HLA matched sibling donors. Transplantation 1974; 18: 295-304.
31. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
32. Clift R, Goldman J, Gratwohl A et al. Proposals for standardized reporting of results of bone marrow transplantation for leukemia. Bone Marrow Transplant 1989; 4: 445-448.
33. Blume KG, Forman SJ, Snyder DS et al. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remission. Transplantation 1987; 43: 389-392.
34. Chao NJ, Forman SJ, Schmidt GM et al. Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission. Blood 1991; 8: 1923-1927.
35. Doney K, Fischer LD, Appelbaum FR et al. Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival. Bone Marrow Transplant 1991; 7: 453-459.
36. Johnson FL, Sanders J, Thomas ED et al. Long-term follow-up after bone marrow transplantation in acute lymphoblastic leukemia. Lancet 1987: i: 380-381.
37. McCarthy DM, Barrett AJ, McDonald J et al. Bone marrow transplantation for adults and children with poor risk acute lymphoblastic leukemia in first complete remission. Bone Marrow Transplant 1988; 3: 315-322.
38. Thomas ED, Sanders JE, Flournoy N et al. Marrow transplantation for patients with acute lymphoblastic leukemia: a long term follow-up. Blood 1983; 62: 1139-1142.
39. Wingard JR, Piantadosi S, Santos GW et al. Allogeneic bone marrow transplantation for patients with high-risk acute lymphoblastic leukemia. J Clin Oncol 1990; 8: 820-830.